This may be because, for auto-reactive T cells to be activated, mutations may have to be present in tumor antigens (55) (to be seen by the immune system as “foreign” antigens) and secondly, effective antigen presentation of the tumor peptide to T cells also requires compatibility with the patient's MHC molecules. Here, HLA-C is linked to neoplasm.